Genvolt Shines at the 15th Academy of Pharmaceutical Science (APS) Conference 2024: Pioneering Innovations in Electrospinning Technology
From September 4th to 6th, 2024, the University of Huddersfield played host to the prestigious 15th Academy of Pharmaceutical Science (APS) Conference. Themed “Beyond the Rules of Five: Pharmaceutical Development Over the Next 20 Years,” the conference brought together the brightest minds in pharmaceutical research and development, attracting academia and industry leaders from around the globe. Among the standout exhibitors was Genvolt Ltd, a company making waves in the field of electrospinning also known as electrohydrodynamic atomisation (EHDA) technology.
The event kicked off with an inspiring keynote by APS chair Ryan Donnelly, who highlighted the future of pharmaceutical development and declared the conference officially open. Over the next three days, attendees were treated to a wide array of breakout sessions, expert talks, and poster presentations, all culminating in a gala dinner and the prestigious APS Fellow Awards, recognising excellence in pharmaceutical science.
Genvolt played a significant role at the conference, proudly serving as a Major Sponsor at the prestigious event. This sponsorship highlighted Genvolt’s commitment to advancing pharmaceutical technologies, and its presence drew significant attention from participants. Numerous attendees made enquiries about Genvolt’s cutting-edge products, opening avenues for potential future sales and business expansion. This engagement underscored the growing interest in Genvolt’s innovative solutions, further solidifying its reputation as a leader in the field.
At the heart of the exhibition floor, Genvolt Ltd stood as a key player, showcasing its latest innovations in electrospinning equipment. As a global leader in the manufacture and supply of high-voltage power supplies and comprehensive electrospinning systems, Genvolt captured the attention of attendees with a live demonstration of its upscaled electrospinning setup. This cutting-edge demonstration allowed participants to witness firsthand the remarkable fibre formation process, in which nanofibres are produced from a polymer solution when electrostatic forces generate a jet cone.
Genvolt’s comprehensive range of electrospinning equipment, from single and multi-syringe pumps to state-of-the-art environmental chambers, was on full display. These systems are designed to meet the ever-growing demands of the pharmaceutical industry, where precision and innovation are paramount.
For years, research into electrospinning has garnered increasing attention, and Genvolt has consistently been at the forefront, driving progress through partnerships with leading institutions. By supporting the advancement of electrospinning technology, Genvolt continues to position itself as a vital contributor to the future of pharmaceutical science.
If you missed Genvolt’s engaging live demonstration at the APS Conference, stay tuned for more updates and innovations as the company continues to lead the charge in electrospinning research and development. With over 30 years of expertise, Genvolt remains a trusted name for researchers and industry leaders alike, helping shape the future of pharmaceutical technologies.
